🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

European shares edge higher; weak China data stokes worries

Published 08/15/2022, 03:46 AM
Updated 08/15/2022, 03:50 AM
© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, August 12, 2022.    REUTERS/Staff
AZN
-
STOXX
-

(Reuters) - European shares inched higher on Monday, boosted by fresh gains for healthcare stocks, while signs of a slowing Chinese economy sparked a flight to sectors such as telecoms and consumer staples typically seen as immune to the economic cycles.

The pan-European STOXX 600 index rose 0.3% by 0720 GMT after hitting two-month highs at the open.

Lifting healthcare stocks, AstraZeneca (NASDAQ:AZN) gained 2.6% after the drugmaker said its cancer drug, Enhertu, developed with Japan's Daiichi Sankyo delayed the progression of a form of advanced breast cancer in previously treated patients.

HelloFresh jumped 8.1% after the German meal-kit maker reported better-than-expected quarterly results.

© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, August 12, 2022.    REUTERS/Staff

Henkel slipped 1.3% as the German consumer goods group said the surging cost of materials hit earnings in the first half of the year.

China-exposed automakers and miners slipped after the country's central bank cut key lending rates in a surprise move to revive demand as data showed the economy unexpectedly slowing in July.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.